Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

OncoQuest Inc. is a clinical development stage biotechnology company which is a subsidiary of Quest Pharmatech (QPT:TSXV), headquartered in Canada, focused on commercializing a portfolio of immuno-modulatory antibodies for the treatment of cancer. These antibodies target a number of tumorigenic proteins, including CA-125, MUC 1, PSA and Her2/neu. Numerous clinical and preclinical studies support the expectation that cancer ...
OncoQuest Inc. is a clinical development stage biotechnology company which is a subsidiary of Quest Pharmatech (QPT:TSXV), headquartered in Canada, focused on commercializing a portfolio of immuno-modulatory antibodies for the treatment of cancer. These antibodies target a number of tumorigenic proteins, including CA-125, MUC 1, PSA and Her2/neu. Numerous clinical and preclinical studies support the expectation that cancer immunotherapies will be most beneficial when utilized as part of combination treatments which may include novel immunotherapies, in addition to well-established approaches such as chemotherapy or radiation.

List your booth number for exhibitions, ask us